Skip to main content
Top
Published in: BMC Clinical Pathology 1/2003

Open Access 01-12-2003 | Research article

The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?

Authors: Ozlem Kurtkaya-Yapicier, Rasim Gencosmanoglu, Erol Avsar, Nadi Bakirci, Nurdan Tozun, Aydin Sav

Published in: BMC Clinical Pathology | Issue 1/2003

Login to get access

Abstract

Background

The purpose of the present correlative immunohistochemical study was to assess the utility of cytokeratin (CK7 and CK20) expression in the diagnosis of short-segment Barrett esophagus, particularly its efficacy in differentiating Barrett mucosa from intestinal metaplasia of the gastric cardia and corpus.

Methods

Two groups of endoscopic biopsy specimens were examined, including 20 endoscopic biopsy specimens of short-segment Barrett esophagus (Group A) and equal number exhibiting Helicobacter pylori associated intestinal metaplasia of the gastric cardia and corpus (Group B). All were investigated by immunohistochemistry using the standard ABC method for CK7 and CK20 expression. Fisher's exact test was used for statistical analysis of Barrett CK7/20 and gastric CK7/20 patterns between the groups.

Results

The anticipated pattern of reactivity in Barrett mucosa (CK7: strong diffuse positivity in superficial and deep glands; CK20: positivity in surface epithelium and superficial glands) was seen in 2 cases of Group A specimens. The expected gastric pattern (CK7: patchy immunostaining with variable involvement of deep glands; CK20: patchy immunostaining of superficial and deep glands in incomplete intestinal metaplasia / absence of CK7 immunoreactivity with strong CK20 staining in superficial and deep glands in complete intestinal metaplasia) was seen in 8 cases of Group B specimens. The respective sensitivity and false-negativity values of CK7/20 staining for Barrett pattern in Group A were 10% and 90%, respectively. These values for gastric pattern in Group B were 40% and 60%, respectively. The specificity and false-positivity values of both patterns were same (100% and 0%, respectively). There was no statistically significant difference for Barrett pattern between the two groups (P = 0.487), while the observation of gastric pattern was significantly higher in Group B than in Group A (P = 0.02).

Conclusions

We concluded that these hypothesized and recently applied diagnostic criteria involving CK7 and CK20 immunoreactivity are not reliable in distinguishing short-segment Barrett esophagus from intestinal metaplasia as seen in gastric cardia and corpus.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Blot WJ, Devesa SS, Fraumeni JF: Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA. 1993, 270: 1320-10.1001/jama.270.11.1320.CrossRefPubMed Blot WJ, Devesa SS, Fraumeni JF: Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA. 1993, 270: 1320-10.1001/jama.270.11.1320.CrossRefPubMed
3.
go back to reference Winters C, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF, Johnson DA, Cruess DF, Cotelingam JD, Gurney MS: Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987, 92: 118-124.CrossRefPubMed Winters C, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF, Johnson DA, Cruess DF, Cotelingam JD, Gurney MS: Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987, 92: 118-124.CrossRefPubMed
4.
5.
go back to reference Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK: The histologic spectrum of Barrett's esophagus. N Engl J Med. 1976, 295: 476-480.CrossRefPubMed Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK: The histologic spectrum of Barrett's esophagus. N Engl J Med. 1976, 295: 476-480.CrossRefPubMed
6.
go back to reference Riddell RH: The biopsy diagnosis of gastroesophageal reflux disease, "carditis", and Barrett's esophagus, and sequelae of therapy. Am J Surg Pathol. 1996, 20: S31-50. 10.1097/00000478-199600001-00005.CrossRefPubMed Riddell RH: The biopsy diagnosis of gastroesophageal reflux disease, "carditis", and Barrett's esophagus, and sequelae of therapy. Am J Surg Pathol. 1996, 20: S31-50. 10.1097/00000478-199600001-00005.CrossRefPubMed
7.
go back to reference Goldblum JR, Vicari JJ, Falk GW, Rice TW, Peek RM, Easley K, Richter JE: Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology. 1998, 114: 633-639.CrossRefPubMed Goldblum JR, Vicari JJ, Falk GW, Rice TW, Peek RM, Easley K, Richter JE: Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology. 1998, 114: 633-639.CrossRefPubMed
8.
go back to reference Ormsby AH, Goldblum JR, Rice TW, Richter JE, Falk GW, Vaezi MF, Gramlich TL: Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol. 1999, 30: 288-294.CrossRefPubMed Ormsby AH, Goldblum JR, Rice TW, Richter JE, Falk GW, Vaezi MF, Gramlich TL: Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol. 1999, 30: 288-294.CrossRefPubMed
9.
go back to reference Glickman JN, Wang H, Das KM, Goyal RK, Spechler SJ, Antonioli D, Odze RD: Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol. 2001, 25: 87-94. 10.1097/00000478-200105000-00002.CrossRefPubMed Glickman JN, Wang H, Das KM, Goyal RK, Spechler SJ, Antonioli D, Odze RD: Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol. 2001, 25: 87-94. 10.1097/00000478-200105000-00002.CrossRefPubMed
10.
go back to reference Couvelard A, Cauvin JM, Goldfain D, Rotenberg A, Robaszkiewicz M, Flejou JF: Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut. 2001, 49: 761-766. 10.1136/gut.49.6.761.CrossRefPubMedPubMedCentral Couvelard A, Cauvin JM, Goldfain D, Rotenberg A, Robaszkiewicz M, Flejou JF: Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut. 2001, 49: 761-766. 10.1136/gut.49.6.761.CrossRefPubMedPubMedCentral
11.
go back to reference Ormsby AH, Vaezi MF, Richter JE, Goldblum JR, Rice TW, Falk GW, Gramlich TL: Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology. 2000, 119: 683-690.CrossRefPubMed Ormsby AH, Vaezi MF, Richter JE, Goldblum JR, Rice TW, Falk GW, Gramlich TL: Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology. 2000, 119: 683-690.CrossRefPubMed
12.
go back to reference Jass JR, Filipe MI: The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma. Histochem J. 1981, 13: 931-939.CrossRefPubMed Jass JR, Filipe MI: The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma. Histochem J. 1981, 13: 931-939.CrossRefPubMed
13.
go back to reference Boyce HW: Endoscopic definitions of esophagogastric junction regional anatomy. Gastrointest Endosc. 2000, 51: 586-592. 10.1067/mge.2000.103674.CrossRefPubMed Boyce HW: Endoscopic definitions of esophagogastric junction regional anatomy. Gastrointest Endosc. 2000, 51: 586-592. 10.1067/mge.2000.103674.CrossRefPubMed
14.
go back to reference Boyce HW: Barrett esophagus: endoscopic findings and what to biopsy. J Clin Gastroenterol. 2003, 36: S6-18. 10.1097/00004836-200305001-00003.CrossRefPubMed Boyce HW: Barrett esophagus: endoscopic findings and what to biopsy. J Clin Gastroenterol. 2003, 36: S6-18. 10.1097/00004836-200305001-00003.CrossRefPubMed
15.
go back to reference Jovanovic I, Tzardi M, Mouzas IA, Micev M, Pesko P, Milosavljevic T, Zois M, Sganzos M, Delides G, Kanavaros P: Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction. Histol Histopathol. 2002, 17: 445-454.PubMed Jovanovic I, Tzardi M, Mouzas IA, Micev M, Pesko P, Milosavljevic T, Zois M, Sganzos M, Delides G, Kanavaros P: Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction. Histol Histopathol. 2002, 17: 445-454.PubMed
16.
go back to reference Mohammed IA, Streutker CJ, Riddell RH: Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mod Pathol. 2002, 15: 611-616.CrossRefPubMed Mohammed IA, Streutker CJ, Riddell RH: Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mod Pathol. 2002, 15: 611-616.CrossRefPubMed
17.
go back to reference El-Zimaity HM, Graham DY: Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol. 2001, 96: 1378-1382. 10.1016/S0002-9270(01)02355-3.CrossRefPubMed El-Zimaity HM, Graham DY: Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol. 2001, 96: 1378-1382. 10.1016/S0002-9270(01)02355-3.CrossRefPubMed
18.
go back to reference DeMeester SR, Wickramasinghe KS, Lord RVN, Friedman A, Balaji NS, Chanrasoma PT, Hagen JA, Peters JH, DeMeester TR: Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol. 2002, 97 (10): 2514-2523. 10.1016/S0002-9270(02)04391-5.CrossRefPubMed DeMeester SR, Wickramasinghe KS, Lord RVN, Friedman A, Balaji NS, Chanrasoma PT, Hagen JA, Peters JH, DeMeester TR: Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol. 2002, 97 (10): 2514-2523. 10.1016/S0002-9270(02)04391-5.CrossRefPubMed
19.
go back to reference Wallner B, Sylvan A, Janunger KG, Bozoky B, Stenling R: Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance. Scand J Gastroenterol. 2001, 36 (9): 910-915. 10.1080/003655201750305404.CrossRefPubMed Wallner B, Sylvan A, Janunger KG, Bozoky B, Stenling R: Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance. Scand J Gastroenterol. 2001, 36 (9): 910-915. 10.1080/003655201750305404.CrossRefPubMed
20.
go back to reference Moll R, Franke WW, Schiller DL, Geiger B, Krepler R: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982, 31: 11-24.CrossRefPubMed Moll R, Franke WW, Schiller DL, Geiger B, Krepler R: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982, 31: 11-24.CrossRefPubMed
21.
go back to reference Oberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, Ireland AP, Richter M, Mason RJ, Crookes P, Bremner CG: Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg. 1997, 226: 522-532. 10.1097/00000658-199710000-00013.CrossRefPubMedPubMedCentral Oberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, Ireland AP, Richter M, Mason RJ, Crookes P, Bremner CG: Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg. 1997, 226: 522-532. 10.1097/00000658-199710000-00013.CrossRefPubMedPubMedCentral
22.
go back to reference Chandrasoma PT, Der R, Ma Y, Dalton P, Taira M: Histology of the gastroesophageal junction: An autopsy study. Am J Surg Pathol. 2000, 24: 402-409. 10.1097/00000478-200003000-00009.CrossRefPubMed Chandrasoma PT, Der R, Ma Y, Dalton P, Taira M: Histology of the gastroesophageal junction: An autopsy study. Am J Surg Pathol. 2000, 24: 402-409. 10.1097/00000478-200003000-00009.CrossRefPubMed
23.
go back to reference Kilgore SP, Ormsby AH, Gramlich TL, Rice TW, Richter JE, Falk GW, Goldblum JR: The gastric cardia: Fact or fiction?. Am J Gastroenterol. 2000, 95: 921-924. 10.1016/S0002-9270(00)00722-X.CrossRefPubMed Kilgore SP, Ormsby AH, Gramlich TL, Rice TW, Richter JE, Falk GW, Goldblum JR: The gastric cardia: Fact or fiction?. Am J Gastroenterol. 2000, 95: 921-924. 10.1016/S0002-9270(00)00722-X.CrossRefPubMed
Metadata
Title
The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
Authors
Ozlem Kurtkaya-Yapicier
Rasim Gencosmanoglu
Erol Avsar
Nadi Bakirci
Nurdan Tozun
Aydin Sav
Publication date
01-12-2003
Publisher
BioMed Central
Published in
BMC Clinical Pathology / Issue 1/2003
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/1472-6890-3-5

Other articles of this Issue 1/2003

BMC Clinical Pathology 1/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.